Click to go to Neuromab Home Click to go to UC Davis Home  
Home      News      Price List      Catalog      Current Projects      Protocols      Suggestions      Publications      Fee-for-Service Rates      Contact Us
Search Publications :
Search Catalog :
News from the UC Davis/NIH NeuroMab Facility

New NeuroMabs (476 total in catalog):

December 21, 2018.  Three new NeuroMabs have been added to the catalog (by Target and NeuroMab clone number): GAD67 (L127/8); GAD65/67 (L127/12) and Prrt2 (N485/22).

November 30, 2018.  Three new NeuroMabs have been added to the catalog (by Target and NeuroMab clone number): Kv4.3 (K75/30); SST/Somatostatin (L111/118) and c-Fos (N486/32).

October 5, 2018.  Three new NeuroMabs have been added to the catalog (by Target and NeuroMab clone number): TrpM4 (L88/86); SAPAP3 (L126/93) and Rufy3 (N483/26).

August 8, 2018.  Two new NeuroMabs have been added to the catalog (by Target and NeuroMab clone number): Rufy3 (N483/84 and N483/126).

 

Other news:

January 1, 2019.  Pricing changes for TC Supernatant and Purified IgG preparations were put into effect by Antibodies Incorporated. Changes include the continuation of the "Exception" pricing category and the elimination of separate prices for Educational or Non-Profit end users and for For-Profit end users. Our prices still remain below the average price of similar highly validated products from commercial sources.

November 29, 2018. The first set of plasmids encoding recombinant NeuroMabs has been made available through Addgene.  https://www.addgene.org/James_Trimmer/

November 1, 2018.  Prices for TC Supernatant and Purified IgG preparations were increased and a new 'Educational or Non-Profit Exception' pricing category was made to offset increased production costs. The non-profit price of $36 for 1.0 mL of TC Supernatant (when obtained in the standard 5.0 mL vial), or for ≈18 ug of pure IgG represents ≈36% of the average price of similar highly validated products from commercial sources.

April 4, 2018.  NeuroMab is now able to offer any/all of our services to one and all on a fee-for-service basis.  See details here.  

August 1, 2017.  Prices for TC Supernatant and Purified IgG preparations were increased to offset increased production costs and to support future NeuroMab projects. The non-profit price of $35 for 1.0 mL of TC Supernatant (when obtained in the standard 5.0 mL vial), or for ≈20 ug of pure IgG represents ≈35% of the average price of similar highly validated products from commercial sources.

May 25, 2017.  Trial sizes of TC Supernatant will no longer be available.  Their price savings to end users was determined to be nominal relative to the already low not-for-profit prices we charge for standard vials of TC supe.

December 8, 2015.  A new section listing NeuroMabs validated for Array Tomography has been added. Validation was performed in part under the auspices of NIH award R01 NS092474 "Synaptomes of Mouse and Man", PI Stephen J. Smith.      

August 1, 2015.  We continue to work towards our mission of generating a library of novel and highly-validated NeuroMabs against neuronal proteins with funding from NIH High Impact Neuroscience Research Resource Grant R24 NS092991.

May 11, 2015.  A "Human Gene Name" column has been added to the catalog to facilitate NeuroMab searches for those who study human genetics.

© Copyright 2019